ACADIA PHARMACEUTICALS INC ($ACAD)
Filing Information
| Accession Number | 0001861477-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 31, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
81,102
Total Value
$432,662.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of Research&Dev | Common Stock | โ | Jul 29, 2026 | Exercise/Conversion | 32,272 | โ | โ | 35,552 | Direct | โ | View Details | |
EVP, Head of Research&Dev | Common Stock | โ | Jul 30, 2026 | Sale | 16,508 | $26.13 | $431,354.04 | 19,044 | Direct | โ | View Details | |
EVP, Head of Research&Dev | Common Stock | โ | Jul 30, 2026 | Sale | 50 | $26.17 | $1,308.50 | 18,994 | Direct | โ | View Details | |
EVP, Head of Research&Dev | Restricted Stock Units | Derivative | Jul 29, 2026 | Exercise/Conversion | 32,272 | $0.00 | $0.00 | 32,272 | Direct | โ | View Details |